drugset / Trial / NCT00640991
REsearching Coronary REduction by Appropriately Targeting Euglycemia (RECREATE Pilot Study)
RandomizedParallel-groupOpen-labelTreatment
Summary
Insulin will safely reduce glucose levels in patients with acute ST-elevation myocardial infarction and admission hyperglycemia.
Timeline
- Start
- 2008-04
- Primary completion
- 2010-06
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin glulisine | Protein / enzyme biologic | — | Intravenous |
| Subject | insulin glargine | Protein / enzyme biologic | — | Subcutaneous |